This paper compares a logistic curve and a mass-action curve in their abilityto represent radiommunoasaystandard curves. A data base from 10 differentassays is used in this comparison. Six of the 10 assays could be modeled equally well by either the logistic or the mass-action curve. In one case the mass-actioncurve gave a slightlybetter fit, though the practical distinction was negligible. In the remaining three assays the mass-action curve performed very much worse than the logistic curve. It is shownthat the mass-actioncurve can assume only a very limited range of shapes, which explains its difficultywith these three assays. In particular, the mass-action curve cannot represent assays where the standard curve slope is less than a specified value. The paper also discussesthe extensionof each of these curves to more complicated equations, and their application to immunoassay data.
In comparing members of the two families of curves, we must compare members of comparable complexity, i.e., with the same number of parameters. Equations 1 and A1.2 fulfil this condition, and both are written with the same response variable.
Thus a direct comparison of the fit of real data to these two curves is possible.
Data Description and Statistical Methods
To obtain a data base on which to make comparisons between equations 1 and A1.2, I obtained data from each of 10 routine assays that were being run at the MRC Immunoassay Team and the Immunoassay section of the Department of Clinical Chemistry, Edinburgh University. For each assay I obtained the four most recent standard curves that had passed the internal quality-control checks. In most cases the data had been inspected by the assayist concerned, and any suspect or anomalous curves were excluded, as were any curves where there appeared to be outlying points or doses. In all cases the assayists also provided the data for total counts, and in some cases an estimate of the concentration of labeled antigen in each tube was available. This corresponds to the actual value of z0. (1) To determine the correct weighting to use in the curve fitting, and in assessing the fit of the curves, I analyzed the scatter of replicate points for each series of four assays to obtain a response-error relationship by a modified likelihood method (8, 9).
In all cases the response-error relationship was satisfactorily fitted by the form
Variance a (expected response)
and the values of J obtained for each analyte are given in Table 1 .
The appropriate weight to be used in the curve fitting for a response with fitted values U, is then Because of all these difficulties, the best-fitting massaction curve for each assay was found by trying out different starting points for the fitting procedure. Again, within each assay series the individual assays showed similar patterns. However, because of cases like the lutropin assay described, the actual values which gave the best fit sometimes varied widely within the same series. program using the NAG library routine EO4CFF (10). All the parameters were constrained to be positive in the singlebinding-site model.
For each standard curve the fit was assessed by comparing the weighted residual mean square for lack-of-fit to the weighted within-replicate mean square. If the fit is satisfactory this ratio will be approximately distributed as a variance ratio whose mean is close to 1. When the same data are fitted to the two models the model that fits better will have the lower variance ratio.
Results

Fitting Difficulties
The fitting of the data to the logistic equation 1 was straightforward for all 40 curves. Within each assay's series of curves, the parameters of all four fitted curves were very similar. Any systematic deviations from the logistive curve also showed the same pattern within each series of four.
The fitting of the single-binding-site model (A1.2) was much more difficult. The fitted curve which the computer reached, from starting values calculated from the data, was not always the best possible curve. This is explained by the fact that quite different values of the set of parameters can give very similar fitted curves. For example, for one lutropin standard curve there were two local minima, giving two curves:
Curve 1: Q = 0.15, z0 = 0, i/K' = 1.39, C = 88 Curve 2: Q = 1.56,zj = 1.61, 1/K' = 0, C = 88 for which the observed and fitted values are given in Table  2 .
These two curves differ by less than 10 counts over the
Comparison of the Fit of the Data to Each of the Two
Curves
The 10-assay series can be classified into three groups. These groups are shown in Table 3 , which also gives the variance ratio for lack-of-fit for the first assay in each series. The six assays in group 1 gave very similar fitted curves for the mass-action model and the logistic curve, so that either curve was equally satisfactory in modeling their standard curves. Two of the assays showed a lack-of-fit to both the curves. For the single assay in group 2, all four standard curves gave a slightly better fit for the mass-action model than for the logistic curve, althoughneither curve was satisfactory in modeling the responses. The assays in group 3 gave a much worse fit for the mass-action curve than for the logistic curve. In two of the three cases the fit of the logistic curve was satisfactory, but in the third case the logistic curve (although better than the mass-action curve) was far from satisfactory in modeling the responses. Figure  1 illustrates the fitted curves for the assay progesterone 2, and shows that the best-fitting mass-action curve here is considerably too steep for the data.
Of the four assays that were not fitted satisfactorily by either curve, three had standard curves that were not symmetric in a plot of counts against log-dose. For the fourth curve (somatotropin) the counts for NSBs did not correspond to the fitted asymptote of either curve. This assay has been discussed in more detail by Birtwhistle Fig. 1 . Plot of counts and fitted curvesfora progesterone assay The solid line showsthe fit ofthe mass-actioncurve,the broken line the fit of the logisticcurve who showed that the curve for high doses makes a more gradual approach to the lower asymptote than does the logistic curve. However, as insufficient data are available to model this correctly in routine assays, he suggests that the results for this assay are best computed by ignoring the NSB counts.
Selected fitted parameters for the assays are given in Table 4 . They help to explain the reasons for the lack of fit to the mass-action curve shown in group 3, and are discussed below. Where the actual concentration of labeled antigen was available, this did not always correspond to the fitted value for z0 obtained from the mass-action curve.
A Comparison of the PossibleShapes of the Two Curves
The shape of the logistic curve plotted against the natural log of the dose is easily described in terms of the parameters. However, we also know (14) that equation A1.2 represents a sigmoid curve with C as its lower asymptote. Although the algebra is complicated, it is straightforward to explore the possible shapes of these curves with the aid of a computer.It can be shown from equation A1.2 that if z0 is varied while the quantities Q/z3 are held constant, the effect on the curve is simply to move it horizontally along the log(dose) axis, without changing its shape. Thus the shape of the single-binding-site curve can be described in terms of the two quantities Q/zo and K'z0.
The proportion of the total counts bound at zero dose was calculated by substituting z = 0 in the single-binding-site equation. When K'z0 is very large the proportion of counts bound is close to Q/z, or equal to one if Q/z exceeds unity.
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The proportion of counts bound at zero dose decreases as K'z0 decreases. Now we can express the response in terms of percent bound, taking the counts bound at zero dose as 100% and the counts for nonspecific binding as 0%. This is equivalent to choosing D -C equal to 100 in the logistic curve. The slope at 50% bound on the single-binding-site curve can then be calculated. These values are given in Tables 5 and 6 for combinations of K'z and Q/z. We can see that for the special case when K'z0 is infinite and Q!zo < 1 the slope is 25, because this corresponds to the slope for a logistic with B = 1. However, the striking feature of Table 5 is that the mass-action equation has a slope at its mid-point that is always 25 and never exceeds 50. Also, the steeper slopes only occur for the high values of K'z0 and QIr4, which result in a high proportion of the counts being bound at zero dose.
These results help to explain why the three assays in group 3 were not adequately modeled by the mass-action curve. In two of the three cases, the fitted value of the parameter B in the logistic model was significantly less than 1. There are no single-binding-site curves that will be sufficiently steep for these assays. For the third assay (follitropin) the fitted logistic parameter (B) is greater than 1, so we might expect that a single-binding-site equation with a large value of Q/z0 and K'z0 would be a good fit. Now the mass-action curve can only achieve such a slope when the percentage of the total counts bound at zero dose is greater than the 25% figure for the follitropin assay. Thus the shape of the mass-action curve in this case is restricted by low binding at zero dose.
We can see from Table 6 that those curves with a slope near the minimum slope are steepest at their midpoint, whereas the steeper curves have points of inflection above 50%. Thus, the mass-action equation can produce asymmetric shapes, but it will only match real asymmetric assay data if the asymmetry of the curve is matched with a particular slope. This explains why the potentially asymmetric mass-action curve did not give an adequate fit to the three asymmetric assays.
Discussion
For the assays investigated here the four-parameter logistic curve is a more satisfactory model of the standard curves than the four-parameter mass-action curve.
The mass-action curve can only attain a limited range of shapes, which makes it a less versatile model to use than the logistic model. Finney (15) has shown that the logistic curve is an adequate approximation to the mass-action curve for a considerable part of the ranges of the parameters K'z0 and Q/z0. If one were to pose the question the other way roundcan the mass-action curve approximate the range of shapes produced by the logistic curve?-it would be found that there are many logistic curves that cannot be approxiated by any single-binding-site mass-action curve. This paper has shown that these shapes occur for real assay data.
Of course, in this investigation I have considered only the simplest four-parameter model of each family of curves. More complicated mass-action curves can be derived by including more than one binding site (4, 6), which usually means introducing at least two more parameters, except in one special case (16). Another five-parameter mass-action curve can be derived by allowing different binding constants for the labeled and unlabeled antigen (17) . For these curves we cannot write U explicitly as a function of the dose and the parameters.
This will give practical problems in obtaining a correctly weighted fit to real data. In view of the difficulties in fitting the simpler model these curves are unlikely to prove of practical value in modeling immunoassay responses.
Naus et al. (17) quote a method for fitting the model with two different binding constants. However, this method uses the dose z as the dependent variable in a regression, which will give biased predictions for the unknowns and will not give valid tests of the fit of the model. The two sets of data that they quote are adequately fitted by four-parameter logistic curves.
The four-parameter logistic equation can be extended in several ways to give asymmetric curves. In developing a model for asymmetric assays (16,18) the following equation has proved the most satisfactory:
This powered logistic has a point of inflection above its midpoint when y < 1, which has been the case for every asymmetric assay that I have encountered. It provides an adequate fit to the three asymmetric assays in this series.
Consequencesfor Dose Interpolation
The practical assayist will ask about the consequences for dose interpolation of the lack-of-fit statistics quoted in Table  3 . Four assays showed no significant lack of fit to either a symmetric logistic or the single-binding-site equation. Thus they are not included here. All the remaining six assays were fitted satisfactorily by either the four-parameter logistic, an asymmetric logistic, or by omitting the counts for nonspecific binding.
For each assay the dose value was read from the various fitted curves at each of four levels of response at 20, 40, 60, and 80% bound (measured with the fitted responses from the "correct" curve as 100% for zero dose and 0% for the nonspecific response).
The deviations between the doses read from the inappropriate curves and those read from the "correct" curve were calculated. These deviations were then averaged for each series of four curves and the results are shown in Table 7 .
It is obvious that considerable systematic errors may be introduced by using the wrong model for the standard curve. This is particularly noticeable for the follitropin and progesterone 2 assays, where the single-binding-site equation produced biased potencies. The result of fitting a symmetric logistic to the asymmetric curves was mainly confined to the low-dose region, but was considerable in two cases.
These levels of response were chosen arbitrarily to give some idea of the magnitude of the systematic errors that can be introduced by using the wrong model. They do not tell the whole story and, in particular, they may miss the part of the dose range where the bias is at its worst. However, they do show that systematic errors of the order of 20% may be introduced by the wrong choice of curve. They underline the importance of using a computer program that includes a statistical evaluation of the fit of the standard curve.
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